In sum, inhibition of EGFL7 or VEGF alone or in combination resulted in fewer and less mature blood vessels in experimental gliomas as well as an increase in animal survival time, in particular in combination with TMD. This evidence concerns the gene EGFL7 and central nervous system cancer.